Strut Health vs Hims for GLP-1 Weight Loss: Which Is Better?

Strut Health vs Hims: Quick Answer

We've spent weeks comparing these two platforms across pricing, medications, support, flexibility, and regulatory standing. Here's where we landed:

That "pick neither" option is important. We'd rather lose a click than steer you toward something that doesn't fit.

Strut Health vs Hims at a Glance (March 2026)

Last reviewed: March 2026 — pricing reviewed from struthealth.com and hims.com. Prices change; always verify before ordering.

Who Should Choose Strut, Hims, or Neither?

This is the section most comparison pages skip — and it's the one that actually matters. You don't need the "best" provider. You need the right provider for your situation.

Choose Hims if…

You want more than just medication. Hims built a full weight-loss ecosystem: GLP-1 injections, oral medication kits (combining ingredients like metformin, bupropion, topiramate, and B12), branded options like Wegovy and Zepbound when available, plus an app with 100+ nutritionist-developed recipes, behavioral programs, sleep tracking, and exercise guidance.

If you value having a well-known, publicly traded brand (NYSE: HIMS) with a large support team and 24/7 provider messaging, Hims delivers that. Their platform feels polished and comprehensive.

The trade-off: their best GLP-1 injectable pricing ($199/mo) typically requires a 6-month plan paid upfront in full — roughly $1,194 out of pocket on day one. That's real money before you've tried the medication. If you're comfortable with that commitment and want the most complete platform experience, Hims makes a strong case.

Choose Strut Health if…

You have one specific need: you want compounded semaglutide, and you especially want it in an oral form that doesn't involve needles.

Strut's standout feature is their sublingual semaglutide lozenge — a daily troche that dissolves under your tongue. For anyone who dreads injections (and that's a lot of people), this changes the entire equation. Lozenges start at roughly $99/month with auto-refill, and there's no multi-month commitment. You pay for one month. If it's not for you, you stop.

Strut also offers injectable compounded semaglutide and, notably, tirzepatide (both oral and injectable). That tirzepatide option matters if you plateau on semaglutide down the road — you can step up without switching providers.

The platform is smaller, more focused, and physician-founded (Dr. Simal Patel, Dallas-based). It doesn't have Hims' app or coaching infrastructure. What it does have is format flexibility and a lower barrier to entry.

Choose neither if…

You only want FDA-approved medication. Full stop.

Compounded GLP-1 medications — which both Strut and Hims offer — are not FDA-approved. They are not generic Wegovy. They are not generic Ozempic. They are custom preparations made by licensed compounding pharmacies, and the FDA has been clear that these products have not gone through the same safety and efficacy review as brand-name drugs.

If that distinction is a dealbreaker for you, here are your better options:

• Brand-name Wegovy is now available self-pay at $349/month through NovoCare (with a $199/month intro offer for the first two months on starter doses).
• Commercial insurance may cover Wegovy or Zepbound with copays as low as $0–$25/month through manufacturer savings programs.
• Your PCP or endocrinologist can prescribe FDA-approved GLP-1s and monitor you in person.

We're an affiliate site. We make money when you sign up through our links. But we'd genuinely rather you go the FDA-approved route than pick a compounded option you're not comfortable with. Trust matters more than a commission.

What Changed in 2025–2026 (and Why This Comparison Needs More Context Now)

If you read a "Strut vs Hims" comparison from 2024, throw it out. The ground shifted under the entire compounded GLP-1 industry, and any comparison that ignores that context is incomplete.

The semaglutide shortage ended

In February 2025, the FDA declared the semaglutide injection shortage officially resolved. That matters more than most people realize.

Here's why: the shortage was the legal basis that allowed compounding pharmacies to mass-produce semaglutide in the first place. Under federal law, compounding pharmacies can make large quantities of brand-name drugs when those drugs are in short supply. Once the shortage ended, that legal pathway narrowed significantly. The FDA gave compounding pharmacies a grace period through April 2025 to wind down, but the message was clear — the wide-open era of compounded GLP-1 production was closing.

This doesn't mean all compounded semaglutide is suddenly illegal. Patient-specific compounding by licensed pharmacies — where a doctor prescribes a custom formulation for a specific patient — remains a legal, regulated practice. But the mass-market, direct-to-consumer model that fueled the compounded GLP-1 boom is under increasing scrutiny.

FDA enforcement escalated

The FDA issued a warning letter to Hims & Hers in September 2025, flagging marketing claims about compounded semaglutide as "false or misleading" under the Federal Food, Drug, and Cosmetic Act. Specifically, the agency took issue with website language like "same active ingredient as Ozempic and Wegovy" and "clinically proven ingredients" — claims the FDA said misled consumers into thinking compounded products were equivalent to FDA-approved medications.

By February 2026, the FDA ramped up further, announcing it would take "decisive steps" to restrict companies from mass-marketing non-FDA-approved GLP-1 products. FDA Commissioner Martin Makary publicly threatened "swift action" against companies selling what the agency considers illegal copycat drugs. The HHS General Counsel also referred Hims & Hers to the Department of Justice for investigation of potential federal law violations.

The agency has been explicit in its position: compounded GLP-1 drugs are "drugs for which the FDA cannot verify quality, safety, or efficacy." That's a strong statement, and you should factor it into your decision regardless of which provider you're considering.

Novo Nordisk went on offense

In February 2026, Novo Nordisk (the maker of Wegovy and Ozempic) filed a patent infringement lawsuit against Hims, seeking a permanent ban on all of Hims' compounded semaglutide products — including their injectable offerings — and seeking to recover damages.

The timeline moved fast: Hims launched a compounded oral semaglutide pill at $49/month on February 5. By February 6, the FDA announced enforcement plans. On February 7, Hims pulled the product. On February 9, Novo filed the lawsuit. A separate consumer class action lawsuit also alleges that Hims' compounded semaglutide doesn't actually contain the same active ingredient as advertised, due to differences in the manufacturing process (chemical synthesis vs. biological production).

Hims has pushed back, calling the lawsuit "a blatant attack by a Danish company on millions of Americans who rely on compounded medications." Hims CEO Andrew Dudum has publicly stated the company will not cave to pharma pressure. But the legal reality is that semaglutide is patent-protected in the U.S. through December 2031 — and Novo Nordisk is well-funded and motivated.

Brand-name pricing dropped significantly

While enforcement was tightening on compounded products, brand-name pricing was dropping — fast.

Novo Nordisk cut Wegovy and Ozempic self-pay prices to $349/month (down from $499). They rolled out a $199/month introductory offer for new self-pay patients on starter doses, available through March 2026. Telehealth partners like Ro, WeightWatchers, and Costco are participating in this pricing.

And looking ahead: starting January 1, 2027, Novo is slashing list prices to $675/month across the board — a 50% cut for Wegovy and a 34% cut for Ozempic. The company has partnered with the Trump administration to provide GLP-1s to Medicare and Medicaid patients at $245/month.

Why this matters for your Strut vs Hims decision: the price gap between compounded and brand-name GLP-1s has narrowed dramatically. In 2023, brand-name Wegovy cost $1,300+/month without insurance. Now it's $349, heading toward $675 list price. Compounded options are still cheaper in most cases, but the cost-benefit calculation is different than it was a year ago — especially when you factor in the higher regulatory certainty of FDA-approved products.

What Will You Actually Pay? Real Cost Comparison

"Starting at $199/month" and "from $99/month" are marketing prices. Here's what you'll likely spend in the real world.

Hims: The Real Cost Math

Hims lists compounded semaglutide injections from $199/month — but that rate applies to a 6-month plan paid upfront in full. That means your day-one cost is approximately $1,194.

Their oral medication kits (which contain non-GLP-1 ingredients like metformin, bupropion, topiramate, and B12) start at $69/month on a 10-month plan — again, paid upfront ($690). It's important to understand: those oral kits are not semaglutide. They work through completely different mechanisms. If you're here because you specifically want GLP-1 medication, the oral kits aren't what you're looking for.

If you want branded FDA-approved GLP-1s through Hims (Wegovy, Ozempic, Zepbound, Mounjaro), expect significantly higher prices — Hims currently lists these from roughly $1,799–$1,999/month — but you get the regulatory certainty of FDA-approved products.

Hims also offers generic liraglutide (the active ingredient in Saxenda) from $299/month on a 12-month plan paid upfront. That's a $3,588 day-one commitment for a different GLP-1 molecule.

Strut Health: The Real Cost Math

Strut's oral semaglutide lozenges start at roughly $99/month with auto-refill (a savings over the standard ~$149/month at the lowest dose). Higher doses cost more as you escalate — up to approximately $349/month at the highest strength (3000mcg). Injectable semaglutide through Strut runs approximately $149–$289/month depending on dosage.

One pricing nuance to note: Strut's own website shows different price points on different pages, which can be confusing. The prices above reflect what we found across their product pages and third-party review sites. Screenshots are the gold standard here — before you order, capture what you see on the checkout page.

The key difference: Strut operates month-to-month. Your day-one cost is one month of medication. Period. If you need to stop after month one because of side effects, cost concerns, or any other reason, you cancel through your account or by contacting [email protected]. Strut asks for at least 48 hours' notice before your next order processes, and refunds are not guaranteed once the pharmacy has filled your order — but there's no long-term contract and no cancellation fee.

Dose Escalation: The Hidden Cost Factor

Here's something most comparison pages completely ignore: your cost probably won't stay at the starting price.

Semaglutide treatment follows a titration schedule — you start at a low dose to let your body adjust, then gradually increase over several months to reach the therapeutic dose where most weight loss occurs.

At Strut, that means you might start at ~$99/month for 250mcg lozenges, move to ~$149/month at 500mcg, and potentially ~$199–$349/month at the higher maintenance doses. Your month-6 cost could be double or triple your month-1 cost.

At Hims, the 6-month prepaid structure means dose changes are handled within your plan — but the flat monthly rate may already account for dose escalation. Verify with Hims exactly how dose changes affect your billing. Bottom line: don't budget based on the starting price alone. Budget for the dose you'll likely need at month 3–6, and you'll avoid unpleasant surprises.

Side-by-Side: What 6 Months Actually Costs

Note on dose escalation: Semaglutide treatment typically starts at a low dose and increases over several months. Your monthly cost may rise as your dose increases. The ranges above reflect that progression. Always verify current pricing directly with each provider.

What Medication Are You Actually Getting?

This is where most comparison pages get sloppy, and it's where you deserve total clarity.

What Hims Offers

• Compounded semaglutide injections — weekly self-injection using a vial and syringe. This is their primary GLP-1 offering.
• Oral weight loss medication kits — daily pills containing combinations of metformin, bupropion, topiramate, naltrexone, and vitamin B12. These are not GLP-1 medications. They work through different mechanisms. Don't confuse them with semaglutide.
• Branded FDA-approved GLP-1s — Hims lists Wegovy, Ozempic, Zepbound, and Mounjaro for qualifying customers. These are FDA-approved products at significantly higher price points ($1,799–$1,999/month). Availability depends on supply and eligibility.
• Generic liraglutide — a different GLP-1 (the active ingredient in Saxenda), available from $299/month on longer plans.

What Strut Health Offers

• Oral semaglutide lozenges — daily sublingual troches that dissolve under the tongue. This is Strut's signature offering and their clearest differentiator. Available in multiple strengths with Vitamin B6. Important: Strut's semaglutide products are only available for patients who fail or cannot use commercially available GLP-1 medications. Medical necessity is required.
• Injectable compounded semaglutide — weekly self-injection (vial + syringes, not an auto-injector pen). Also requires documented medical necessity.
• Oral and injectable tirzepatide — a GLP-1/GIP dual-receptor agonist for patients who need a stronger option or have plateaued on semaglutide. Also requires documented medical necessity.
• Zero Crave Rx — a combination of bupropion, naltrexone, and B12 (similar concept to Hims' oral kits, targeting cravings and appetite through non-GLP-1 mechanisms).

Oral Semaglutide Lozenge vs Weekly Injection: Which Fits Your Life?

This is the question that makes the Strut vs Hims comparison interesting. On Hims' current pricing pages, the compounded GLP-1 options they promote are injections — their oral kits are not GLP-1 medications. Strut gives you both injection and oral GLP-1 options.

Why Some People Want the Oral Route

Let's be honest: a lot of people looking at GLP-1s are hesitant about self-injecting. That's not weakness — it's normal.

Strut's sublingual lozenge (called a "troche") dissolves under your tongue once daily. No needles, no vials, no alcohol swabs, no finding an injection site. You put it under your tongue in the morning, let it dissolve for a few minutes, and go about your day.

For travelers, people with needle phobia, or anyone who just prefers the simplicity of a daily lozenge, this format is a genuine advantage. Research supports oral semaglutide in general — the OASIS 1 trial, published in The Lancet, found that participants taking a once-daily 50 mg oral semaglutide tablet lost an average of 15.1% of their body weight over 68 weeks. Important note: OASIS 1 studied a specific oral tablet formulation, not Strut's compounded sublingual troche. The two delivery methods are different, and the trial results should not be assumed to apply directly to Strut's lozenge.

When the Injection May Still Be the Better Choice

Weekly injections have a deeper evidence base. The STEP 1 trial (published in the New England Journal of Medicine) showed an average weight loss of about 14.9% of body weight with injectable semaglutide over 68 weeks.

Injections also mean you only think about your medication once a week instead of every day. For people who struggle with daily adherence, that once-a-week ritual can actually be easier to maintain long-term. And because injectable delivery bypasses the digestive system entirely, absorption is more predictable.

Neither format is objectively "better." The best one is the one you'll actually stick with.

Safety, Legitimacy, and the Real Risks

This is the section most affiliate pages water down. We're not going to do that. If you're putting a compound into your body, you deserve straight answers.

Is Strut Health Legit?

• Physician-founded: Strut was founded by Dr. Simal Patel and operates out of Dallas, TX.
• U.S.-licensed pharmacies: Strut states that all compounding pharmacies they work with are U.S.-licensed and regulated.
• Trustpilot: 750+ reviews. Check Trustpilot for the current score.
• BBB rating: D+. Driven by unresolved complaints and failure to respond to at least one filed complaint.
• FDA warning letter (February 2026): The FDA sent Strut a warning letter over false or misleading claims — specifically, labeling that implied Strut was the compounder of products it did not compound, and claims implying compounded products were equivalent to FDA-approved medications.

Our take: Strut is an operational telehealth platform with a focused product line. The BBB rating and the FDA warning letter are real concerns — not dealbreakers on their own, but worth knowing. The physician-led structure and Trustpilot review volume suggest a real business serving real customers.

Is Hims Legit?

• Publicly traded: Hims & Hers Health is listed on the NYSE (HIMS), meaning financial disclosures, audits, and public accountability.
• Scale: Over 1 million customers across all products.
• BBB rating: A+.
• FDA warning letter (September 2025): The FDA flagged Hims' marketing claims about compounded semaglutide as "false or misleading" under federal law.
• Novo Nordisk lawsuit (February 2026): Novo filed a patent infringement suit seeking to permanently ban Hims from selling compounded semaglutide.

Our take: Hims is a large, publicly traded company with a well-built platform. Their weight-loss ecosystem is genuinely robust. But the regulatory and legal situation in early 2026 is real. Their compounded GLP-1 injectables remain available as of this writing, but the Novo Nordisk lawsuit creates uncertainty.

Support Experience: What Happens After You Sign Up

The medication is only part of the equation. What's the actual experience like once you're a customer?

If you want to be guided through the weight-loss process with structured support and resources, Hims wins this category clearly. If you want to get your medication, check in with a doctor when you need to, and handle the lifestyle piece on your own, Strut is perfectly adequate — and you'll spend less doing it.

Shipping, Cancellation, and State Availability

These operational details seem boring until they trip you up. Let's knock them out.

What Real Users Are Saying

We're keeping this section short intentionally. Testimonials are useful for texture, not proof. Three honest snapshots:

What If Neither Strut nor Hims Fits?

If you want FDA-approved GLP-1s (the highest regulatory certainty)

• Wegovy (semaglutide injection): The gold standard. Currently available self-pay at $349/month through NovoCare, with a $199/month intro offer for the first two months on starter doses through March 2026.
• Zepbound (tirzepatide injection): Eli Lilly's FDA-approved GLP-1/GIP dual-agonist for weight loss. Available through LillyDirect at $299–$699 depending on dose. Tirzepatide has shown slightly higher average weight loss than semaglutide in head-to-head trials.
• Through your insurance: If your health plan covers GLP-1 medications, your out-of-pocket could be as low as $25/month for eligible commercially insured patients using manufacturer savings cards.

If you want to compare more compounded providers

The GLP-1 telehealth market is crowded. Strut and Hims aren't your only options. We've reviewed over a dozen GLP-1 telehealth platforms across pricing, trust, and user experience. See our full comparison of the best semaglutide providers →

If you want the most conservative, doctor-supervised approach

Start with your primary care physician (PCP) or an endocrinologist. They can:

• Run baseline labs (metabolic panel, thyroid function, A1C)
• Prescribe FDA-approved GLP-1s with clinical monitoring
• Adjust treatment based on in-person assessments
• Manage comorbidities alongside weight management

How We Compared Strut Health and Hims

What to Expect in Your First Month (Whichever You Choose)

Since you're this deep into the article, you're probably close to making a decision. Here's a realistic preview of what the first 30 days look like:

The Final Verdict

You've now read more about Strut Health vs Hims than 99% of people comparing these two platforms. Here's our recommendation one more time:

The right answer isn't the cheapest ad you saw or the biggest brand name. It's the provider that matches your format preference, your budget tolerance, your support needs, and your comfort level with compounded medications. You've done the research. You know what you're getting. Now pick the path that fits — and start.

Strut Health vs Hims: FAQ